Author: Smead Capital Management

Reuters: Cole Smead on the Outcome of AI

  Wall Street edges higher in thin post-holiday trade By Sabrina Valle and Pranav Kashyap For more information go to reuters.com. The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

Financial Times: Cole Smead, CFA on Orcel and European Banks

What next for Andrea Orcel’s UniCredit? By Simon Foy, European Banking Correspondent For more information go to www.ft.com. Stocks mentioned: UCG The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice. Past performance

⟶ Keep Reading

Calgary Herald: Cole Smead, CFA on MEG Acquisition

Varcoe: One more curveball in $8.6-billion takeover bid for MEG Energy By Chris Varcoe For more information go to www.calgaryherald.com. Stocks mentioned: CVE, MEG, SCR The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice.

⟶ Keep Reading

Reuters: Bill Smead on New UnitedHealthcare CEO

  UnitedHealth investors pin turnaround hopes on new CEO By Amina Niasse and Sriparna Roy For more information go to reuters.com. Stocks mentioned: UNH The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice.

⟶ Keep Reading

Moneywise: Bill Smead on the Market Frenzy Around AI

This chief investor is urging people to quit chasing this 1 stock sector, saying it’s not if but when ‘this thing breaks’ — is your portfolio ready?by Jessica Wong For more information go to www.moneywise.com. The information contained in this article represents SCM’s opinions, and

⟶ Keep Reading
Scroll to Top